Eu Biologics Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eu Biologics Co Ltd with three other
companies in this sector in South Korea:
ISU Abxis Company Limited
sales of 16.75 billion Korean Won [US$14.20 million]
of which 99%
was Antibody Medicine),
(22.32 billion Korean Won [US$18.92 million]
of which 87%
was The clinical trial agent), and
Choong Ang Vaccine Laboratory
(33.15 billion Korean Won [US$28.11 million]
of which 100%
was Animal Health Product).
Eu Biologics Co Ltd reported sales of 24.89 billion Korean Won (US$21.11 million)
December of 2018.
increase of 115.2%
versus 2017, when the company's sales were 11.57 billion Korean Won.
This was the third consecutive year of growth at Eu Biologics Co Ltd.